| Literature DB >> 24244829 |
Jin Bae Weon1, Bo-Ra Yun, Jiwoo Lee, Min Rye Eom, Hyun-Jeong Ko, Ji Seon Kim, Hyeon Yong Lee, Dong-Sik Park, Hee-Chul Chung, Jae Youn Chung, Choong Je Ma.
Abstract
Codonopsis lanceolata (Campanulaceae) traditionally have been used as a tonic and to treat patients with lung abscesses. Recently, it was proposed that the extract and some compounds isolated from C. lanceolata reversed scopolamine-induced memory and learning deficits. The purpose of this study was to evaluate the improvement of cognitive enhancing effect of C. lanceolata by steam and fermentation process in scopolamine-induced memory impairment mice models by passive avoidance test and Morris water maze test. The extract of C. lanceolata or the extract of steamed and fermented C. lanceolata (SFCE) was orally administered to male mice at the doses of 100 and 300 mg/kg body weight. As a result, mice treated with steamed and fermented C. lanceolata extract (SFCE) (300 mg/kg body weight, p.o.) showed shorter escape latencies than those with C. lanceolata extract or the scopolamine-administered group in Morris water maze test. Also, it exerted longer step-through latency time than scopolamine treated group in passive avoidance test. Furthermore, neuroprotective effect of SFCE on glutamate-induced cytotoxicity was assessed in HT22 cells. Only SFCE-treated cells showed significant protection at 500 μg/ml. Interestingly, steamed C. lanceolata with fermentation contained more phenolic acid including gallic acid and vanillic acid than original C. lanceolata. Collectively, these results suggest that steam and fermentation process of C. lanceolata increased cognitive enhancing activity related to the memory processes and neuroprotective effect than original C. lanceolata.Entities:
Keywords: Codonopsis lanceolata; Cognitive-enhancing activity; Fermentation; Morris water maze test; Neuroprotective effect; Passive avoidance test; Steaming
Year: 2013 PMID: 24244829 PMCID: PMC3825205 DOI: 10.4062/biomolther.2013.055
Source DB: PubMed Journal: Biomol Ther (Seoul) ISSN: 1976-9148 Impact factor: 4.634
Fig. 1.Escape latency in the Morris water maze during four days. The Morris water maze test of mice treated with (A) control, (B) scopolamine, (C) donepezil, (D) scopolamine+SFCE (100 mg/kg), (E) scopolamine+SFCE (300 mg/kg), (F) scopolamine+C. lanceolata (100 mg/kg) and (G) scopolamine+C. lanceolata (300 mg/kg), respectively. The values shown are the mean escape latency ± SD (n=7). Escape latency of the trial 2 significantly differ from the value in trial 1: *p<0.05, **p<0.01 and ***p<0.001. #p<0.05, ##p<0.01 and ###p<0.001 compared with scopolamine group. Results were analyzed by two-way ANOVA.
Fig. 2.(A) The time spent in the quadrant where the platform was once placed in probe test. Results are expressed as mean ± SD (n=7). *p<0.05, **p<0.01 and ***p<0.001 compared with scopolamine group. Results were analyzed by one-way ANOVA. (B) The typical swimming routes of each group in Morris water maze test. control group, scopolamine treated group, scopolamine+donepezil treated group,scopolamine+C. lanceolata (300 mg/kg), scopolamine+SFCE (300 mg/kg).
Fig. 3.Effect of SFCE on scopolamine-induced memory impairment mice in Passive avoidance test: (A) training trial, (B) test trial. The values shown the mean latency time (s) ± SD (n=7). #p<0.05 compared with control group. *p<0.05 compared with scopolamine group.
Fig. 4.The neuroprotective effects of SFCE and C. lanceolata against glutamate-induced cytotoxicity in neuronal HT22 cells. Each bar represents the mean relative protection ± SD of three independent experiments. *p<0.05, **p<0.01 and ***p<0.001 vs. glutamate-injured cells.
Fig. 5.The contents of phenolic compounds in the SFCE and C. lanceolata. Significantly different from the C. lanceolata (*p<0.05).